Page 30 - Inspire
P. 30

The decision to have a vaccination is a personal one.
      It may be based on weighing up the benefits and risks to
      the individual, their family and the broader community.
      However, there is evidence that the vaccine can reduce
      the risk of severe illness and hospitalisation if someone
      is exposed to the virus.


      You may be asked about your current treatment and
      any severe allergies you may have. It’s recommended you
      have your vaccination before treatments such as
      immunotherapy. If you have any concerns or questions
      please check with your healthcare team.

      Many people have no significant reaction to the
      vaccination apart from some tenderness in the arm
      around the site of the injection. Others have mild flu-like
      symptoms. If you have any worrying or long-lasting
      reactions, please tell your medical team.                    Your chest surgeon will use your full lung
                                                                   function test results to try to calculate what
                                                                   impact losing more of your lung will have on
                                                                   your breathing.

                                                                   It may be worth considering a non-surgical
                                                                   approach to treating the tumour in the other lung.

                                                                   I’m sure the consultant clinical oncologist in
      There’s now several mutations or molecular                   your team would be keen to talk to you about
      markers within an individual cancer cell that help           stereotactic radiotherapy which could be offered
      your oncologist determine the best drug treatment            with curative intent.
      for you.


      This has dramatically improved lung cancer treatment
      over the past 10 years. Prior to that, everyone with
      non-small cell lung cancer was treated the same.

      There’s even better news too. More drugs are being
      developed that may be active in many of the mutations
      and markers that we have now identified. These are
      called targeted therapies.
   25   26   27   28   29   30   31   32